global production Chempacific operates two production facilities, Baltimore and Zhejiang, enabling regional development and scalable manufacturing from development to commercial production. This presents a sales opportunity to offer end-to-end API and intermediate production services across multiple scales and regulatory environments.

specialty focus Specialty chemical, bulk chemical, intermediate and API production capabilities position Chempacific to pursue partnerships with pharma, biotech, agrochemical and specialty polymer firms seeking custom synthesis, scale-up and compliant manufacturing for niche or high-value compounds.

growth potential With revenue in the mid-range and a lean employee base, there may be capacity for additional contract manufacturing work and value-added services such as process development, analytical support, and cGMP-compliant scale-up to support expanding client pipelines.

technical edge A core organic chemistry platform and scale-up technology underpin robust capability to take projects from milligrams to metric tons, making Chempacific attractive for customers needing reliable transition from development to production with consistent quality and timelines.

global reach Dual-location footprint allows proximity to development activities in the US and commercial-scale production in China, enabling co-location benefits, risk diversification, and potential for multi-site manufacturing agreements with global pharmaceutical and chemical brands.